SkyVision Electronics was founded, successfully completing a Seed Round financing of US$15 million, establishing its patent portfolio, and validating its core technology through Proof of Concept (POC).
The company's disposable spinal endoscope (Spinoscopy) advanced into preclinical studies and completed key engineering milestones, including Engineering Validation Test (EVT), Design Validation Test (DVT), and Production Validation Test (PVT), achieving production readiness.
Completed key clinical studies and successfully secured US$30 million in Series A financing.
Signed a distributor agreement with a major industry partner for more than 1,000 units, and successfully launched shipments across Taiwan, Malaysia, and Indonesia.
Successfully secured US$60 million in Series A+ financing.
Advanced the Taiwan TFDA regulatory approval process and executed a comprehensive Go-to-Market (GTM) strategy to accelerate commercial adoption.
The Company plans to initiate its Series B financing, while pursuing U.S. FDA clearance to fully enter the U.S. market.
In parallel, we will launch a next-generation disposable arthroscope (under TFDA and FDA regulatory submission) and an AI-assisted surgical system, advancing toward a fully integrated smart surgical ecosystem.